U.S. stockpiles more bird-flu vaccine from 3 firms

Share this article:
The Department of Health and Human Services is buying $199.45 million more worth of vaccines designed to protect against the H5N1 avian flu virus. HHS Secretary Mike Leavitt said the government awarded three contracts: a $117.9 million contract to Sanofi Pasteur for 3.7 million doses, a $40.95 million contract to Novartis for 800,000 doses and a $40.6 million to GlaxoSmithKline for 800,000 doses. The vaccines represent enough doses for nearly 2.7 million people. The purchases supplement the existing national stockpile of 5.9 million doses of H5N1 vaccine and build on the department’s plans to buy enough vaccine for 20 million people, HHS said in a statement.
Share this article:

Email Newsletters

More in News

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.

Valeant bids $47B for Allergan

Valeant bids $47B for Allergan

The deal would bring Allergan's Botox and Juvederm under the same roof as Restylane.